Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (8799)	7/4/2003 8:51:57 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 52153

<<Now of course SEPR can still sign a co-promote deal (just as they did with Abbott and Xopenex) - I'm assuming they would wait for approval before doing so. But there have been no hints at all from SEPR that they might consider doing this.>> Didn’t SEPR indicate that they will not built internal sales force until FDA blessing. At that time it is too late, so I think that they will partner at right time. Partner will need to have sale force in place, or available to do job, imo. Miljenko